Human melanocytes as a model system for studies of Alzheimer disease

Archives of Dermatology

Volumn 133, Issue 10, 1997, Pages 1287-1291

  Yaar, Mina ^a   Gilchrest, Barbara A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BASIC FIBROBLAST GROWTH FACTOR; CELL SURFACE RECEPTOR; DNA; ENDOTHELIN 1; INTERMEDIN; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; PROTEIN BAX; PROTEIN TYROSINE KINASE; RECEPTOR; STEM CELL FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

AGING; ALZHEIMER DISEASE; APOPTOSIS; CELL DEATH; CLINICAL TRIAL; HUMAN; MELANOCYTE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030750476     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.10.1287     Document Type: Review

References (41)

1. Gilchrest BA. Skin aging and photoaging: an overview. J Am Acad Dermatol. 1989; 21:610-613.
2. Halaban R, Fan B, Ahn J, Funasaka Y, Gitay-Goren H, Neufeld G. Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes. J Immunother. 1992;12:154-161.
3. Ferguson IA, Johnson E Jr. Fibroblast growth factor receptor-bearing neurons in the CNS: identification by receptor-mediated retrograde transport. J Comp Neurol. 1991;313:693-706.
4. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem. 1992;267: 24675-24680.
5. Krsmanovic LZ, Stojilkovic SS, Balla T, al-Damluji S, Weiner RI, Catt KJ. Receptors and neurosecretory actions of endothelin in hypothalamic neurons. Proc Natl Acad Sci U S A. 1991;88:11124-11128.
6. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol. 1994;8:1298-1308.
7. Grabbe J, Welker P, Dippel E, Czarnetzki BM. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res. 1994; 287:78-84.
8. Peacocke M, Yaar M, Mansur CP, Chao MV, Gilchrest BA. Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci U S A. 1988; 85:5282-5286.
9. Yaar M, Eller MS, DiBenedetto P, Reenstra WR, Zhai S, McQuaid T, et al. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest. 1994;94:1550-1562.
10. Selkoe DJ. Aizheimer's disease: genotypes, phenotypes, and treatments. Science. 1997;275:630-631.
11. Kelly JF, Furukawa K, Barger SW, et al. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc Natl Acad Sci U S A. 1996;93:6753-6758.
12. Lee RK, Wurtman RJ, Cox AJ, Nitsch RM. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc Natl Acad Sci U S A. 1995;92:8083-8087.
13. Manelli AM, Puttfarcken PS. beta-Amyloid-induced toxicity in rat hippocampal cells: in vitro evidence for the involvement of free radicals. Brain Res Bull. 1995; 38:569-576.
14. Takadera T, Sakura N, Mohri T, Hashimoto T. Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention. Neurosci Lett. 1993;161:41-44.
15. Wolozin B, Iwasaki K, Vito P, et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science. 1996;274: 1710-1713.
16. Pedersen WA, Kloczewiak MA, Blusztajn JK. Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A. 1996;93:8068-8071.
17. Kusiak JW, Izzo JA, Zhao B. Neurodegeneration in Alzheimer disease: is apoptosis involved? Mol Chem Neuropathol. 1996;28:153-162.
18. Zhai S, Yaar M, Gilchrest BA. Mechanism of β amyloid induced apoptosis in neural crest-derived cells. J Invest Dermatol. 1996;106:809. Abstract.
19. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron. 1991;6: 487-498.
20. Allsopp TE, Wyatt S, Paterson HF, Davies AM. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 1993; 73:295-307.
21. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-619.
22. Negoescu A, Lorimier P, Labat-Moleur F, et al. In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. J Histochem Cytochem. 1996;44:959-968.
23. Seiger A, Nordberg A, von Holst H, et al. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a positive future treatment strategy. Behav Brain Res. 1993;57:255-261.
24. Lapchak PA. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp Neurol. 1993;124: 16-20.
25. Olson L, Nordberg A, von Holst H, et al. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect. 1992; 4:79-95.
26. Zhai S, Yaar M, Doyle SM, Gilchrest BA. Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. Exp Cell Res. 1996;224:335-343.
27. Kaplan DR, Martin-Zanca D, Parada LF. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NIGF. Nature. 1991; 350:158-160.
28. Chao MV, Bothwell MA, Ross AH, et al. Gene transfer and molecular cloning of the human NGF receptor. Science. 1986;232:518-521.
29. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 1991;350:678-683.
30. Feinstein E, Kimchi A, Wallach D, Boldin M, Varfolomeev E. The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci. 1995;20:342-344.
31. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/AP01 contains a sequence motif related to the death domain. J Biol Chem. 1995;270:7795-7798.
32. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 1996;383:716-719.
33. Ibanez CF, Ebendal T, Barbany G, Murray-Rust J, Blundell TL, Persson H. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell. 1992;69:329-341.
34. White JV, Stultz CM, Smith TF. Protein classification by stochastic modeling and optimal filtering of amino-acid sequences. Math Biosci. 1994;119:35-75.
35. Landreth GE, Shooter EM. Nerve growth factor receptors on PC12 cells: ligand-induced conversion from low-to high-affinity states. Proc Natl Acad Sci U S A. 1980;77:4751-4755.
36. Meakin SO, Suter U, Drinkwater CC, Welcher AA, Shooter EM. The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor. Proc Natl Acad Sci U S A. 1992;89:2374-2378.
37. Rabizadeh S, Bitler CM, Butcher LL, Bredesen DE. Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc Natl Acad Sci U S A. 1994;91:10703-10706.
38. Zhai S, Yaar M, Pilch PF, Doyle SM, Gilchrest BA. A cyclic decapeptide blocks β amyloid mediated apoptotic cell death. J Invest Med. 1997;45:202A. Abstract.
39. Selkoe DJ. Normal and abnormal biology of the beta-amyloid precursor protein. Ann Rev Neuro. 1994;17:489-517.
40. Larkfors L, Ebendal T, Whittemore SR, Persson H, Hoffer B, Olson L. Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain. Brain Res. 1987;427:55-60.
41. Yaar M, Zhai S, Pilch PF, Doyle SM, Gilchrest BA. Design of a cyclic decapeptide to block apoptotic cell death mediate through the p75 neurotrophin receptor. J Invest Dermatol. 1997;108:568. Abstract.